Thought Leadership
Email Page
Discretionary Denials at Patent Court Thwart Generic Drugmakers
November 1, 2019
Valerie Bauman
Bloomberg Law

Axinn partner Aziz Burgy and associate Michelle Divelbiss were quoted in the Bloomberg Law article, "Discretionary Denials at Patent Court Thwart Generic Drugmakers."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.